HeartSciences Inc.
For the period ended Apr 30, 2026. Filed Jul 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jul 23, 2026
HSCS$2.71-4.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
INDEX TO FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 200) | F-2 |
|---|---|
| Balance Sheets as of April 30, 2026 and 2025 | F-3 |
| Statements of Operations for the Years Ended April 30, 2026 and 2025 | F-4 |
| Statement of Stockholders’ Equity for the Year Ended April 30, 2026 | F-5 |
| Statement of Stockholders’ Equity for the Year Ended April 30, 2025 | F-6 |
| Statements of Cash Flows for the Years Ended April 30, 2026 and 2025 | F-7 |
| Notes to Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.